Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease
- 14 September 2020
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (11) , 1181-1188
Abstract
Objective To compare the diagnostic accuracy and the prognostic value of blood and cerebrospinal fluid (CSF) tests across prion disease subtypes. Methods We used a single-molecule immunoassay to measure tau and neurofilament light chain (NfL) protein levels in the plasma and assessed CSF total(t)-tau, NfL and protein 14-3-3 levels in patients with prion disease (n=336), non-prion rapidly progressive dementias (n=106) and non-neurodegenerative controls (n=37). We then evaluated each plasma and CSF marker for diagnosis and their association with survival, taking into account the disease subtype, which is a strong independent prognostic factor in prion disease. Results Plasma tau and NfL concentrations were higher in patients with prion disease than in non-neurodegenerative controls and non-prion rapidly progressive dementias. Plasma tau showed higher diagnostic value than plasma NfL, but a lower accuracy than the CSF proteins t-tau and 14-3-3. In the whole prion cohort, both plasma (tau and NfL) and CSF (t-tau, 14-3-3 and NfL) markers were significantly associated with survival and showed similar prognostic values. However, the intrasubtype analysis revealed that only CSF t-tau in sporadic Creutzfeldt-Jakob disease (sCJD) MM(V)1, plasma tau and CSF t-tau in sCJD VV2, and plasma NfL in slowly progressive prion diseases were significantly associated with survival after accounting for covariates. Conclusions Plasma markers have lower diagnostic accuracy than CSF biomarkers. Plasma tau and NfL and CSF t-tau are significantly associated with survival in prion disease in a subtype-specific manner and can be used to improve clinical trial stratification and clinical care.Keywords
Funding Information
- Ministero della Salute (Ricerca corrente)
This publication has 31 references indexed in Scilit:
- Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuICJournal of Neurology, 2019
- Recent advances in the histo‐molecular pathology of human prion diseaseBrain Pathology, 2018
- Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseasesAlzheimer's & Dementia, 2018
- The CSF neurofilament light signature in rapidly progressive neurodegenerative dementiasAlzheimer's Research & Therapy, 2018
- Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levelsActa Neuropathologica, 2017
- Diagnostic and prognostic value of human prion detection in cerebrospinal fluidAnnals of Neurology, 2016
- A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob diseaseNeurology, 2012
- Sporadic human prion diseases: molecular insights and diagnosisThe Lancet Neurology, 2012
- The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year reviewJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsAnnals of Neurology, 1999